Efficacy and safety of bupropion extended release in elderly patients with major depressive disorder

被引:5
作者
Chrzanowski, W.
Rousseau, R.
Hewett, K.
Gee, M. D.
Wightman, D.
Richard, N. E.
Modell, J. G.
Goodale, E. P.
机构
[1] Psychiat Clin Med Acad Bialystok, Choroszcs, Poland
[2] Aurora Clin Trials, Miami, FL USA
[3] GlaxoSmithKline Inc, Res & Dev, Harlow, Essex, England
[4] GlaxoSmithKline Inc, Res & Dev, Res Triangle Pk, NC USA
关键词
D O I
10.1016/S0924-977X(06)70340-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S315 / S316
页数:2
相关论文
共 2 条
[1]   Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials [J].
Thase, ME ;
Haight, BR ;
Richard, N ;
Rockett, CB ;
Mitton, M ;
Modell, JG ;
VanMeter, S ;
Harriett, AE ;
Wang, YH .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) :974-981
[2]   Bupropion sustained release versus paroxetine for the treatment of depression in the elderly [J].
Weihs, KL ;
Settle, EC ;
Batey, SR ;
Houser, TL ;
Donahue, RMJ ;
Ascher, JA .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (03) :196-202